| http://www.w3.org/ns/prov#value | - Exclusion Criteria: Known allergy to ranibizumab; acute cardiovascular event requiring hospitalization within the past 3 months; systemic anti-VEGF or pro-VEGF treatment within 3 months prior to randomization or anticipated use during study; macular edema is considered to be due to a cause other than DME
|
